BCYC — Bicycle Therapeutics Share News
0.000.00%
Last trade - 00:00- $267.37m
- -$241.92m
- $72.59m
UK's Bicycle Therapeutics Q3 loss narrows as expenses fall
Bicycle Therapeutics PLC expected to post a loss of 43 cents a share - Earnings Preview
UK's Bicycle Therapeutics Q2 net loss narrows on reduced clinical program expenses
Bicycle Therapeutics Q1 revenue drops after partnership terminations
Brief: Bicycle Therapeutics Announces Oral And Poster Presentations At The Aacr Annual Meeting 2026
UK's Bicycle Therapeutics Q4 revenue jumps, proposes 30% workforce reduction
Brief: Bicycle Therapeutics Says Travis Thompson Appointed As CFO, Succeeds Alethia Young
Bicycle Therapeutics Q3 net loss widens as R&D costs rise
Brief: Bicycle Therapeutics Increases Board Size To Ten Directors - SEC Filing
Brief: Bicycle Therapeutics Strengthens Board Of Directors With New Appointments
Brief: Bicycle Therapeutics PLC Files For Mixed Shelf Offering Of $500 Million- SEC Filing
Bicycle Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary
Bicycle Therapeutics falls on wider Q2 net loss
Bicycle Therapeutics Q2 net loss widens to $79 mln
Bicycle Therapeutics PLC expected to post a loss of 95 cents a share - Earnings Preview
Brief: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Bicycle Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary
Brief: Bicycle Therapeutics Announces Presentation Of Additional Human Radiopharmaceutical Imaging Data For Mt1-Mmp At The American Association For Cancer Research Annual Meeting 2025